Medication-info.com Search Menu

Cardamyst (Etripamil): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
70 mg/0.2 mL
Active ingredient:

Patient information: uses, side effects, how to take - Cardamyst

What is CARDAMYST?

CARDAMYST is a prescription medicine used to help restore normal heart rhythm in adults who have symptoms of sudden episodes of fast heartbeat called paroxysmal supraventricular tachycardia (PSVT).

It is not known if CARDAMYST is safe and effective in children.

Do not use CARDAMYST if you:

  • are allergic to CARDAMYST or to any of its ingredients. See the end of this leaflet for a complete list of ingredients in CARDAMYST.
  • have limitations in activities due to heart failure (moderate to severe heart failure).
  • have Wolff-Parkinson-White (WPW) syndrome, Lown-Ganong-Levine (LGL) syndrome, or an abnormal heart rhythm pattern called pre-excitation (delta wave) on an electrocardiogram (ECG).
  • have sick sinus syndrome without a permanent pacemaker.
  • have second degree or higher atrioventricular (AV) block.

Before using CARDAMYST, tell your healthcare provider about all of your medical conditions, including if you:

  • have a history of fainting.
  • have low blood pressure.
  • are pregnant or plan to become pregnant. It is not known if CARDAMYST will harm your unborn baby.

  • are breastfeeding or plan to breastfeed. It is not known if CARDAMYST passes into your breast milk. You should stop breastfeeding for 12 hours after treatment with CARDAMYST. During this time, pump and throw away your breast milk. Talk to your healthcare provider about the best way to feed your baby after using CARDAMYST.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use CARDAMYST?

  • Read the Instructions for Use that comes with CARDAMYST for information about the right way to use CARDAMYST.
  • Use CARDAMYST exactly as prescribed by your healthcare provider.
  • CARDAMYST is for use in the nose only.
  • Each CARDAMYST device contains 1 dose consisting of 2 sprays (1 spray in each nostril).
  • Do not test, prime, or press the plunger before use. The nasal spray device is ready for use.
  • Use CARDAMYST as soon as possible after your PSVT symptoms begin.
  • While sitting, insert the CARDAMYST device into the nostril and spray one spray in each nostril by pressing the plunger firmly and quickly all the way up and releasing it between each spray.
  • Stay seated and keep your head straight for 10 minutes.
  • If you still have symptoms after 10 minutes, give a second dose (1 spray in each nostril) with a new CARDAMYST device.
  • If your symptoms do not improve within 20 minutes after your second dose, call your healthcare provider or get emergency medical help right away.
  • If you do not receive the full first dose (1 spray in each nostril) because the device did not work or was used incorrectly, wait at least 10 minutes before giving a second dose, if needed.
  • Do not use more than 2 CARDAMYST devices (140 mg) within a 24-hour period.
  • Do not re-use the CARDAMYST device. Throw away (discard) the CARDAMYST device after use.
  • If you use too much CARDAMYST, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of CARDAMYST?

CARDAMYST may cause serious side effects, including:

  • Fainting due to CARDAMYST effects on blood pressure, heart rate, and electrical activity of the heart. CARDAMYST may cause dizziness and fainting, especially in people with a history of fainting and certain heart problems, or people with a history of fainting during an episode of PVST. Use CARDAMYST while sitting in a safe area where you will not fall if you become dizzy or lightheaded. Lie down if you feel dizzy or lightheaded after using CARDAMYST. If fainting occurs after using CARDAMYST, caregivers should place you on your back and seek medical help.

The most common side effects of CARDAMYST include:

  • nasal discomfort
  • nasal congestion
  • runny nose
  • throat irritation
  • nosebleed

These are not all of the possible side effects of CARDAMYST.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store CARDAMYST?

  • Store CARDAMYST at room temperature between 68°F to 77°F (20°C to 25°C).

Keep CARDAMYST and all medicines out of the reach of children.

General information about the safe and effective use of CARDAMYST.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use CARDAMYST for a condition for which it was not prescribed. Do not give CARDAMYST to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about CARDAMYST that is written for health professionals.

What are the ingredients in CARDAMYST?

Active ingredient: etripamil

Inactive ingredients: acetic acid, edetate disodium, sulfuric acid and water for injection.

Manufactured for: Milestone Pharmaceuticals USA, Inc., 6210 Ardrey Kell Road, Suite 650, Charlotte, NC, 28277

For more information about CARDAMYST, visit cardamyst.com or call 1-844-805-5810.

INSTRUCTIONS FOR USE

Cardamyst™ [kar da mist]

(etripamil) nasal spray

This Instructions for Use contains information on how to use CARDAMYST nasal spray.

Important Information You Need to Know Before Using CARDAMYST

  • For use in the nose only.
  • Each CARDAMYST device contains 1 dose consisting of 2 sprays (1 spray in each nostril). Do not press the CARDAMYST device plunger until you are ready to deliver a dose.
  • Check the expiration date (‘EXP’) before using.
  • Do not test or prime before use. The nasal spray device is ready for use.
  • CARDAMYST may cause dizziness. Use CARDAMYST while sitting in a safe area where you will not fall if you become dizzy or lightheaded.
  • If you do not get the full first dose, wait 10 minutes before using another device.
  • Do not re-use the CARDAMYST device. Throw away (discard) the CARDAMYST device after use.

CARDAMYST Device

Preparing the DoseUsing CARDAMYST Nasal Spray

Remove the CARDAMYST device from the carrying case:

  • Each carrying case contains 2 CARDAMYST devices. Each CARDAMYST device contains 1 dose consisting of 2 sprays (1 spray for each nostril).
  • Open the lid and carefully remove 1 nasal spray device from the carrying case.

Sit down and hold the nasal spray device in your hand:

  • Hold the CARDAMYST device in an upright position as shown with your thumb on the bottom of the plunger and the tip between your index and middle fingers.
  • Do not press the plunger yet.

Insert the nasal spray device into the first nostril and spray:

  • Keep your head straight.
  • Insert the tip of the nasal spray device into 1 nostril until your index and middle finger are touching the bottom of your nose.
  • Using your thumb, press the plunger firmly and quickly all the way up.
  • Breathe normally. Avoid inhaling deeply.
Using CARDAMYST Nasal Spray (continued)

Release the plunger:

  • Completely release the plunger.
  • Remove the nasal spray device from the first nostril.

Insert the same nasal spray device into the second nostril and spray right away:

  • With the same nasal spray device, repeat Steps 3 and 4 in the second nostril right away.
  • Breathe normally. Avoid inhaling deeply.

Stay seated and keep your head straight for 10 minutes:

  • For CARDAMYST to work right away, keep your head straight for 10 minutes, as shown.
  • When medicine drips out, wipe your nose.
  • Do not blow your nose for 10 minutes.
  • Throw away (discard) the CARDAMYST device after use.

If you continue to have symptoms after 10 minutes:

  • Repeat Steps 1 to 6 with a new CARDAMYST device.
  • If your symptoms have not improved within 20 minutes after your second dose, call your healthcare provider or get emergency medical help right away.
  • Do not use more than 2 CARDAMYST devices (140 mg) within a 24 hour period.
  • Replace the used CARDAMYST device with a new one right after use, so you will have a new nasal spray device in case you need it.

Storing CARDAMYST

Store CARDAMYST at room temperature between 20°C to 25°C (68°F to 77°F).Keep CARDAMYST and all medicines out of the reach of children.

For more information about CARDAMYST, visit cardamyst.com or call 1-844-805-5810.

Manufactured for: Milestone Pharmaceuticals USA, Inc., 6210 Ardrey Kell Road, Suite 650, Charlotte, NC 28277

This Instructions for Use has been approved by the U.S. Food and Drug Administration. Issued: December 2025

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 218571 · View the label on DailyMed

Revision date stated in the text: December 2025

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Cardamyst

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Etripamil 70 mg/0.2 mL
Dosage form Spray
Route Nasal
Marketing status listed in the FDA NDC Directory
Company (applicant) MILESTONE PHARMS USA
FDA approval NDA 218571New Drug Application (NDA) Approved December 12, 2025
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
70 mg/0.2 mL – 0.2 ml in 1 vial, single-dose / 2 in 1 container / 2 in 1 carton NDC 83468-070-01

Source: FDA drug labeling via NLM DailyMed, data as of November 11, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.